초록 ▼

A description is given of a microcapsule formulation comprising microcapsules having a core of a hydrophobic material and a capsule shell of an addition polymer containing in copolymerized form at least 1% by weight of cationogenic monomers and/or polyethylenically unsaturated monomers whose unsatur

A description is given of a microcapsule formulation comprising microcapsules having a core of a hydrophobic material and a capsule shell of an addition polymer containing in copolymerized form at least 1% by weight of cationogenic monomers and/or polyethylenically unsaturated monomers whose unsaturated sites are connected via successive chemical bonds of which at least one bond is acid-hydrolyzable. A description is further given of a microcapsule formulation comprising microcapsules having a core of a hydrophobic material, which comprises at least one fragrance or perfume, and a shell of an addition polymer containing in copolymerized form at least 1% by weight of anionogenic monoethylenically unsaturated monomers and/or polyethylenically unsaturated monomers whose unsaturated sites are connected via successive chemical bonds of which at least one bond is base-hydrolyzable. The microcapsule formulations are employed in laundry detergents or cleaning products.

대표청구항 ▼

1. A microcapsule formulation comprising,microcapsules of an average diameter of from 1 to 100 μm, having a core of a hydrophobic material and a capsule shell of an addition polymer containing in copolymerized form at least 10% by weight of cationogenic monomer(s) and/or polyethylenically unsaturate

1. A microcapsule formulation comprising,microcapsules of an average diameter of from 1 to 100 μm, having a core of a hydrophobic material and a capsule shell of an addition polymer containing in copolymerized form at least 10% by weight of cationogenic monomer(s) and/or polyethylenically unsaturated monomer(s) whose unsaturated sites are connected via successive chemical bonds of which at least one bond is acid-hydrolyzable, wherein the microcapsules are obtained by dispersing an oil phase in an aqueous medium to obtain a stable oil-in-water emulsion, the oil phase containing the hydrophobic material and a monomer mixture constituting the capsule shell, polymerizing the monomer mixture in the oil phase of the stable oil-in-water emulsion, wherein the polymer produced from the polymerization is soluble neither in the oil phase nor in the water phase of the oil-in-water emulsion and migrates to the interface between the oil droplets and the water phase and ultimately encases the hydrophobic material. 2. The microcapsule formulation of claim 1, wherein said cationogenic monomer(s) comprise aminoalkyl (meth)acrylates and/or aminoalkyl(meth)acrylamides.3. The microcapsule formulation of claim 1, wherein said polyethylenically unsaturated monomer(s) having an acid-hydrolyzable bond comprise alkylenebis(meth)acrylamides.4. The microcapsule formulation of claim 1, wherein said hydrophobic material comprises at least one fragrance or perfume.5. The microcapsule formulation as claimed in of claim 1, wherein said hydrophobic material comprises at least one constituent selected from the group consisting of bleach activators, foam suppressants, optical brighteners, and enzymes.6. The microcapsule formulation of claim 1, in spray-dried form.7. A method for making a laundry detergent for textiles or a cleaning product for nontextile surfaces, skin or hair comprising adding the microcapsule formulation of claim 1 to a laundry detergent or cleaning product.8. A laundry detergent or cleaning product composition comprising microcapsules havinga core of a hydrophobic material, which comprises at least one fragrance or perfume, and a shell of an addition polymer containing in copolymerized form at least 10% by weight of anionogenic monoethylenically unsaturated monomer(s) and/or polyethylenically unsaturated monomer(s) whose unsaturated sites are connected via successive chemical bonds of which at least one bond is base-hydrolyzable, the weight proportion of the hydrophobic core material with respect to the entire capsule being from 50 to 98%, wherein the microcapsules are obtained by dispersing an oil phase in an aqueous medium to obtain a stable oil-in-water emulsion, the oil phase containing the hydrophobic material and a monomer mixture constituting the capsule shell, polymerizing the monomer mixture in the oil phase of the stable oil-in-water emulsion, wherein the polymer produced from the polymerization is soluble neither in the oil phase nor in the water phase of the oil-in-water emulsion and migrates to the interface between the oil droplets and the water phase and ultimately encases the hydrophobic material. 9. The composition of claim 8, wherein said anionogenic monomer(s) comprise ethylenically unsaturated C3-C6 monocarboxylic acids or C4-C6 dicarboxylic acids or monoesters or intramolecular anhydrides of ethylenically unsaturated C4-C6 dicarboxylic acids.10. The composition of claim 8, wherein said polyethylenically unsaturated monomer(s) having a base-hydrolyzable bond comprise anhydrides of monoethylenically unsaturated C3-C6 monocarboxylic acids.11. The composition of claim 8, further comprising at least one constituent selected from the group consisting of surfactant(s) and builder(s), or both.12. The composition of claim 8, wherein said fragrance comprises one or more compounds selected from the group consisting of orange oil, lemon oil, rose extract, lavender, musk, patchouli, balsam essence, sandalwood oil, pine oil, and cedar oil.13. The composition of claim 8, wherein said fragrance comprises one or more compounds selected from the group consisting of 7-acetyl-1,2,3,4,5,6,7,8-octahydro-1,1,6,7-tetramethyl-naphthalene, α-ionone, β-ionone, γ-ionone α-isomethylionone, methylcedrylone, methyl dihydrojasmonate, methyl 1,6,10-trimethyl-2,5,9-cyclododecatrien-1-yl ketone, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, 4-acetyl-6-tert-butyl-1,1-dimethylindane, hydroxyphenylbutanone, benzophenone, methyl β-naphthyl ketone, 6-acetyl-1,1,2,3,3,5-hexamethylindane, 5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane, 1-dodecanal, 4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carboxaldehyde, 7-hydroxy-3,7-dimethyloctanal, 10-undecen-1-al, isohexenylcyclohexylcarboxaldehyde, formyltricyclodecane, condensation products of hydroxycitronellal and methyl anthranilate, condensation products of hydroxycitronellal and indole, condensation products of phenylacetaldehyde and indole, 2-methyl-3-(para-tert-butylphenyl)propionaldehyde, ethylvanillin, heliotropin, hexylcinnamaldehyde, amylcinnamaldehyde, 2-methyl-2-(isopropylphenyl)propionaldehyde, coumarin, γ-decalactone, cyclopentadecanolide, 16-hydroxy-9-hexadecenoic acid lactone, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-cyclopenta-γ-2-benzopyran, β-naphthol methyl ether, ambroxane, dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1b]furan, cedrol, 5-(2,2,3-trimethylcyclopent-3-enyl)-3-methylpentan-2-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)2-buten-1-ol, caryophyllene alcohol, tricyclodecenyl propionate, tricyclodecenyl acetate, benzyl salicylate, cedryl acetate, and tert-butylcyclohexyl acetate.14. The composition of claim 8, wherein said fragrance comprises one or more compounds selected from the group consisting of Peru balsam, olibanum resinoid, styrax, labdanum resin, nutmeg, cassia oil, benzoin resin, coriander, lavandin, phenylethyl alcohol, terpineol, linalool, linalyl acetate, geraniol, nerol, 2-(1,1-dimethylethyl)cyclo-hexanol acetate, benzyl acetate, and eugenol.15. The microcapsule formulation of claim 1, wherein said hydrophobic material comprises one or more compounds selected from the group consisting of orange oil, lemon oil, rose extract, lavender, musk, patchouli, balsam essence, sandalwood oil, pine oil, cedar oil, Peru balsam, olibanum resinoid, styrax, labdanum resin, nutmeg, cassia oil, benzoin resin, coriander, lavandin, phenylethyl alcohol, terpineol, linalool, linalyl acetate, geraniol, nerol, 2-(1,1-dimethylethyl)cyclo-hexanol acetate, benzyl acetate, and eugenol.16. The microcapsule formulation of claim 1, wherein said hydrophobic material comprises one or more compounds selected from the group consisting of 7-acetyl-1,2,3,4,5,6,7,8-octahydro-1,1,6,7-tetramethylnaphthalene, α-ionone, β-ionone, γ-ionone α-isomethylionone, methylcedrylone, methyl dihydrojasmonate, methyl 1,6,10-trimethyl-2,5,9-cyclododecatrien-1-yl ketone, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, 4-acetyl-6-tert-butyl-1,1-dimethylindane, hydroxyphenylbutanone, benzophenone, methyl β-naphthyl ketone, 6-acetyl-1,1,2,3,3,5-hexamethylindane, 5-acetyl-3-isopropyl-1,1,2,6-tetramethylindane, 1-dodecanal, 4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carboxaldehyde, 7-hydroxy-3,7-dimethyloctanal, 10-undecen-1-al, isohexenylcyclohexylcarboxaldehyde, formyltricyclodecane, condensation products of hydroxycitronellal and methyl anthranilate, condensation products of hydroxycitronellal and indole, condensation products of phenylacetaldehyde and indole, 2-methyl-3-(para-tert-butylphenyl)propionaldehyde, ethylvanillin, heliotropin, hexylcinnamaldehyde, amylcinnamaldehyde, 2-methyl-2-(isopropylphenyl)propionaldehyde, coumarin, γ-decalactone, cyclopentadecanolide, 16-hydroxy-9-hexadecenoic acid lactone, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-cyclopenta-γ-2-benzopyran, β-naphthol methyl ether, ambroxane, dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1b]furan, cedrol, 5-(2,2,3-trimethylcyclopent-3-enyl)3-methylpentan-2-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, caryophyllene alcohol, tricyclodecenyl propionate, tricyclodecenyl acetate, benzyl salicylate, cedryl acetate, and tert-butylcyclohexyl acetate.17. The microcapsule formulation of claim 1, wherein said capsule shell comprises one or more cationogenic monomer(s) selected from the group consisting of aminoalkyl(meth)acrylate(s) and aminoalkyl(meth)acrylamide(s).18. The microcapsule formulation of claim 1, wherein said capsule shell comprises one or more cationogenic monomer(s) of formula I: where the radicals R independently of one another are hydrogen, C1-C8 alkyl, C1-C8 hydroxyalkyl or polyoxy(C1-C4)alkylene of 2 to 500 alkylene units or two radicals R together with the nitrogen atom to which they are attached form a 5- to 8-membered ring; R1 is C1-C18 alkylene and R2 is hydrogen or methyl. 19. The microcapsule formulation of claim 1, wherein said cationogenic monomer is selected from the group consisting of at least one compound of formula II: where the radicals R independently of one another are hydrogen, C1-C8 alkyl, C1-C8 hydroxyalkyl or polyoxy(C1-C4)alkylene of 2 to 500 alkylene units or two radicals R together with the nitrogen atom to which they are attached form a 5- to 8-membered ring; R1 is C1-C18 alkylene; and R2 is hydrogen or methyl. 20. The microcapsule formulation of claim 1, wherein said capsule shell comprises one or more cationogenic monomer(s) selected from the group consisting of N-dimethylaminopropylmethacrylamide, N,N-dimethylaminoethyl methacrylate, N,N-dimethylaminoethyl acrylate, 2-tert-butylaminoethyl methacrylate, 2-N-morpholinoethyl methacrylate, 2-N-morpholinoethyl acrylate, and 3-dimethylaminoneopentyl acrylate.21. The microcapsule formulation of claim 1, wherein said capsule shell comprises at least one polyethylenically unsaturated monomer(s) having an acid-hydrolyzable bond which is an alkylenebis(meth)acrylamide(s).22. The microcapsule formulation of claim 1, wherein said capsule shell comprises at least one polyethylenically unsaturated monomer(s) having an acid-hydrolyzable bond which is an alkylenebis(meth)acrylamide(s) of the formula III: where the radicals R independently of one another are hydrogen, C1-C8 alkyl, C1-C8 hydroxyalkyl or polyoxy(C1-C4)alkylene of 2 to 500 alkylene units or two radicals R together with the nitrogen atom to which they are attached form a 5 to 8-membered ring; R1 is C1-C18 alkylene; and R2 is hydrogen or methyl. 23. The microcapsule formulation of claim 1, wherein said capsule shell comprises at least one polyethylenically unsaturated monomer(s) having an acid-hydrolyzable bond which is selected from the group consisting of N,N′-methylenebisacrylamide and N,N′-hexamethylenebismethacrylamide.24. A method for pH-mediated release of an encapsulated material comprising:exposing microcapsules to a pH of about 2 to 7, wherein said microcapsules have an average diameter of from 1 to 100 μm, comprise a core of a hydrophobic material and a capsule shell of an addition polymer containing in copolymerized form at least 1% by weight of cationogenic monomer(s) and/or polyethylenically unsaturated monomer(s) whose unsaturated sites are connected via successive chemical bonds of which at least one bond is acid-hydrolyzable. 25. A method for pH-mediated release of an encapsulated material comprising:exposing microcapsules to a pH of about 8 to 14, wherein said microcapsules have an average diameter of from 1 to 100 μm, comprise a core of a hydrophobic material and a capsule shell of an addition polymer containing in copolymerized form at least 1% by weight of anionogenic monomer(s) and/or polyethylenically unsaturated monomer(s) whose unsaturated sites are connected via successive chemical bonds of which at least one bond is base-hydrolyzable. 26. The microcapsule formulation of claim 18, wherein two radicals R together with the nitrogen atom to which they are attached form a saturated 5- to 8-membered ring.27. The microcapsule formulation of claim 18, wherein R1 is C2-C6 alkylene.